Skip to content

DR. SOFIE MASSCHELEIN

Active
Private limited companyfounded 20188 yrs activeDiksmuidse Heirweg 12, 8210 Zedelgem, BelgiumKBO/BCE: BE 0700.929.918

DR. SOFIE MASSCHELEIN has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €113k and a net result of €80k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 30% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
83 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency62▼-38
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 1.55 against 15.67 in 2024; short-term debt: 63.4% and cash: 72.1% of total assets), but 63.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
36.6%
Return on assets
25.9%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
59 d early
2024
48 d early
2023
36 d early
2022
26 d early
2021
18 d early
2020
22 d early
2019
44 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€113k▼ 52.5%
2024 · €237k
2018: €68k 2019: €143k 2020: €214k 2021: €330k 2022: €19k 2023: €113k 2024: €237k
2018 → 2025
Total assets
€307k▲ 21.7%
2024 · €253k
2018: €100k 2019: €169k 2020: €260k 2021: €350k 2022: €136k 2023: €134k 2024: €253k
2018 → 2025
Net result
€80k▼ 36.4%
2024 · €125k
2018: €56k 2019: €69k 2020: €72k 2021: €116k 2022: €96k 2023: €94k 2024: €125k
2018 → 2025
Working capital
€107k▼ 53.5%
2024 · €231k
2018: €68k 2019: €133k 2020: €207k 2021: €324k 2022: €14k 2023: €112k 2024: €231k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€330k-€19k▼ 94.4%€113k▲ 505%€237k▲ 110%€113k▼ 52.5%
Operating result€147k-€121k▼ 17.5%€131k▲ 8.1%€160k▲ 22.0%€99k▼ 38.1%
Net result€116k-€96k▼ 16.7%€94k▼ 2.4%€125k▲ 33.1%€80k▼ 36.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €147k€147kNet result 2021: €116k€116kOperating result 2022: €121k€121kNet result 2022: €96k€96kOperating result 2023: €131k€131kNet result 2023: €94k€94kOperating result 2024: €160k€160kNet result 2024: €125k€125kOperating result 2025: €99k€99kNet result 2025: €80k€80k20212022202320242025
The operating result falls in 2025; 2025 is 38% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €307k
Fixed assets €5k▼ 11.0%
Current assets €302k▲ 22.5%
Equity and liabilities €307k
Equity €113k▼ 52.5%
Debt €195k▲ 1,138%
The debt ratio rises from 6.2% to 63.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€100k
2024 · €161k
Cash flow
€80k
2024 · €126k
Solvency
36.6%
2024 · 93.8%
Current ratio
1.55
2024 · 15.67
Quick ratio
1.55
2024 · 15.67
Debt / equity
1.73
2024 · 0.07
ROE
70.6%
2024 · 52.8%
ROA
25.9%
2024 · 49.5%
Interest coverage
314.25
2024 · 561.75
Debt
€195k
2024 · €16k
Debt ≤ 1 year
€195k
2024 · €16k
Income taxes
€21k
2024 · €36k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€253k€307k
Fixed assets21/28€6k€5k
Tangible fixed assets22/27€6k€5k
Furniture and vehicles24€0-
Other tangible fixed assets26€6k€5k
Current assets29/58€247k€302k
Amounts receivable after more than one year29€50k€50k=
Other amounts receivable291€50k€50k=
Amounts receivable within one year40/41€14k€25k
Trade receivables40-€33
Other amounts receivable41€14k€25k
Cash at bank and in hand54/58€178k€222k
Deferred charges and accrued income490/1€5k€5k
Equity and liabilities
Total equity and liabilities10/49€253k€307k
Equity10/15€237k€113k
Contributions10/11€19k€19k=
Reserves13€218k€94k
Distributable reserves133€218k€94k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€16k€195k
Amounts payable within one year42/48€16k€195k
Trade debts44€50€20
Suppliers440/4€50€20
Taxes, remuneration and social security45€13k€7k
Taxes450/3€10k€4k
Remuneration and social security454/9€2k€2k=
Other amounts payable47/48€3k€188k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€668
Other operating charges640/8€733€864
Gross operating margin9900€162k€101k
Operating profit (loss)9901€160k€99k
Financial income75/76B€2k€2k=
Recurring financial income75€2k€2k=
Financial charges65/66B€287€318
Recurring financial charges65€287€318
Profit (loss) for the period before taxes9903€161k€100k
Income taxes67/77€36k€21k
Profit (loss) for the period9904€125k€80k
Profit (loss) for the period to be appropriated9905€125k€80k
Appropriation of the result
Profit (loss) to be appropriated9906€125k€80k
Transfer from equity791/2-€124k
Transfer to equity691/2€124k€0
To other reserves6921€124k€0
Profit to be distributed694/7€859€204k
Return on contributions (dividend)694€859€204k

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
02-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
13-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2018net €125k ▲33.1%
Operating result €160k, net result €125k, both a record.
31-12
Financial Liquidity triplescurrent ratio 15.67
Current ratio from 6.20 to 15.67; short-term debt falls from €22k to €16k.
31-12
Financial Equity above €200kEq €237k ▲110%
7 profitable years in a row build equity to €237k.
25-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Liquidity times 6current ratio 6.20
Current ratio from 1.12 to 6.20; short-term debt falls from €117k to €22k.
31-12
Financial Equity above €100kEq €113k ▲505%
6 profitable years in a row build equity to €113k.
05-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
13-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Liquidity triplescurrent ratio 17.30
Current ratio from 5.65 to 17.30; short-term debt falls from €45k to €20k.
09-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Equity above €200kEq €214k ▲50.2%
3 profitable years in a row build equity to €214k.
17-06
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Liquidity doublescurrent ratio 6.59
Current ratio from 3.08 to 6.59; short-term debt falls from €33k to €24k.
31-12
Financial Equity above €100kEq €143k ▲110%
2 profitable years in a row build equity to €143k.
03-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zedelgem · 1 establishment unit since 2018
seat establishment The establishment unit on the map
Ground area
1,414 m²
Building footprint
392 m²
Volume, LiDAR
1,961 m³
2 parcels, Flanders · tallest building 8.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Sofie Masschelein Burg.V. BVBA
Diksmuidse Heirweg 12A, 8210 ZedelgemGeneral medical practice
since 20182.279.488.419
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31040A0236/00H000 Flanders 1,067 m² 1 · 177 m² 8.5 m · 2 fl.
31040A0236/00L000 Flanders 347 m² 1 · 214 m² 7.2 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,344 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded17-08-2018
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.